2.39MGBP
Type
Common Stock
Exchange
LSE
Currency Code
GBX
Currency Name
Pence sterling
Country Name
UK
Country ISO
GB
ISIN
GB00BLH13C52
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.03
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.01
Wall Street Target Price
6.00
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
49,775
Gross Profit TTM
49,775
EBITDA
-1,874,675
Profit Margin
0.00%
Return On Assets TTM
-36.21%
Return On Equity TTM
-58.74%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
418.50%
Diluted Eps TTM
-0.01
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
35.7239
Price Book MRQ
0.3902
Enterprise Value Revenue
2
Enterprise Value EBITDA
-5
321.00
2.39%1.77
1.85%129.20
1.57%119.80
1.10%1960.00
1.03%105.50
0.96%985.00
0.00%202.50
0.00%1378.00
-1.77%0.91
-0.28%